These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 12840547

  • 21. Fibrillization of alpha-synuclein and tau in familial Parkinson's disease caused by the A53T alpha-synuclein mutation.
    Kotzbauer PT, Giasson BI, Kravitz AV, Golbe LI, Mark MH, Trojanowski JQ, Lee VM.
    Exp Neurol; 2004 Jun; 187(2):279-88. PubMed ID: 15144854
    [Abstract] [Full Text] [Related]

  • 22. Caspase-cleaved tau accumulation in neurodegenerative diseases associated with tau and alpha-synuclein pathology.
    Newman J, Rissman RA, Sarsoza F, Kim RC, Dick M, Bennett DA, Cotman CW, Rohn TT, Head E.
    Acta Neuropathol; 2005 Aug; 110(2):135-44. PubMed ID: 15986225
    [Abstract] [Full Text] [Related]

  • 23. Atypical protein kinase C in neurodegenerative disease II: PKCiota/lambda in tauopathies and alpha-synucleinopathies.
    Shao CY, Crary JF, Rao C, Sacktor TC, Mirra SS.
    J Neuropathol Exp Neurol; 2006 Apr; 65(4):327-35. PubMed ID: 16691114
    [Abstract] [Full Text] [Related]

  • 24. Beta-amyloid treatment of two complementary P301L tau-expressing Alzheimer's disease models reveals similar deregulated cellular processes.
    David DC, Ittner LM, Gehrig P, Nergenau D, Shepherd C, Halliday G, Götz J.
    Proteomics; 2006 Dec; 6(24):6566-77. PubMed ID: 17111439
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Oxysterols and neurodegenerative diseases.
    Björkhem I, Cedazo-Minguez A, Leoni V, Meaney S.
    Mol Aspects Med; 2009 Jun; 30(3):171-9. PubMed ID: 19248803
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Neuropathology of primary restless leg syndrome: absence of specific tau- and alpha-synuclein pathology.
    Pittock SJ, Parrett T, Adler CH, Parisi JE, Dickson DW, Ahlskog JE.
    Mov Disord; 2004 Jun; 19(6):695-9. PubMed ID: 15197711
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Interface between tauopathies and synucleinopathies: a tale of two proteins.
    Galpern WR, Lang AE.
    Ann Neurol; 2006 Mar; 59(3):449-58. PubMed ID: 16489609
    [Abstract] [Full Text] [Related]

  • 36. Detection of protein aggregation in neurodegenerative diseases.
    Deng HX, Bigio EH, Siddique T.
    Methods Mol Biol; 2011 Mar; 793():259-72. PubMed ID: 21913106
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Covalent blocking of fibril formation and aggregation of intracellular amyloidgenic proteins by transglutaminase-catalyzed intramolecular cross-linking.
    Konno T, Morii T, Hirata A, Sato S, Oiki S, Ikura K.
    Biochemistry; 2005 Feb 15; 44(6):2072-9. PubMed ID: 15697232
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.